ArticleThe Lancet. Infectious diseases2020
Dominance of M1
Article in The Lancet. Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed.
- Tracing the recent evolution of Group AEmerging microbes & infections · 2026Review
- Molecular characterization of covRS mutations in M1FEBS open bio · 2026Article
- Whole Genome Sequencing Analysis of Group AJournal of Korean medical science · 2026Article
- Emergence of distinct Streptococcus pyogenes emm1 and emm12 lineages in China.Nature microbiology · 2026Article
- Acquisition of toxin-encoding lysogenic bacteriophage elements enhances the virulence of pandemicInfection and immunity · 2026Article
- Molecular epidemiology and antimicrobial susceptibility of group A Streptococcus isolated from children in Greece during 2023.Infection · 2026Article
- Evidence for early circulation of the M1UK sublineage of Streptococcus pyogenes in Germany, 2015-2023.Emerging microbes & infections · 2025Article
- Severe invasiveJournal of intensive medicine · 2025Article
- Core-genome Single-nucleotide Polymorphism Analysis ofAnnals of laboratory medicine · 2025Article
- Risk Factors for Severe Pediatric Invasive Group A Streptococcal Disease.JAMA network open · 2025Observational
- Group A Streptococcal Invasive Infections Among Children in Cyprus.Microorganisms · 2025Article
- Post-pandemic upsurge in Group AMicrobiology spectrum · 2025Article
- A Rapid Molecular Detection Tool for Toxigenic M1UK Streptococcus pyogenes.The Journal of infectious diseases · 2025Article
- Characterization of a novelmBio · 2025Article
- Article
- Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasiveJournal of clinical microbiology · 2024Article
- Invasive Group A Streptococcal Infections in Europe After the COVID-19 Pandemic.Deutsches Arzteblatt international · 2024Review
- Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
- Divergent effects ofJournal of clinical microbiology · 2024Article
- Molecular characterization ofMicrobial genomics · 2024Article
Corrections and comments
- Comment on
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32359464What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.